Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-02

Clinical Trial Update: Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Kaletra and Maraviroc in ART-naive HIV patients was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kaletra (lopinavir)
  • Maraviroc (maraviroc)

Snippet

Sponsor: Temple University | Conditions: HIV Infections | Phase 4 | Status: TERMINATED | Results posted: 2020-11-02